Copyright © Inderes 2011 - present. All rights reserved.

BioInvent International

27.8

 

SEK

 

+9.45 %

BINV

NASDAQ Stockholm

Biotechnology & Pharmaceuticals

Health Care

Less than 1K followers
Compare
+9.45%
-1.42%
-27.79%
-36.67%
-29.44%
+71.39%
-23.71%
-14.25%
-97.08%

BioInvent International is a biotechnology company focused on the development of innovative antibody therapies for cancer treatment. The company is researching new treatments that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe, North America and Asia. BioInvent International was founded in 2001 and is headquartered in Lund, Sweden.

Read more
Market cap
1.83B SEK
Turnover
5.58M SEK
Revenue
44.69M
EBIT %
-1,054.15 %
P/E
-
Dividend yield-%
-
Financial calendar
29.4
2025

General meeting '25

29.4
2025

Interim report Q1'25

26.8
2025

Interim report Q2'25

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.